Mapping the structural brain changes in Alzheimers Disease: The independent contribution of two imaging modalities

Journal of Alzheimer's Disease

Volumn 26, Issue SUPPL. 3, 2011, Pages 263-274

  Canu, Elisa ^a,f   McLaren, Donald G ^b,c,d   Fitzgerald, Michele E ^b,d   Bendlin, Barbara B ^b,d   Zoccatelli, Giada ^e   Alessandrini, Franco ^e   Pizzini, Francesca B ^e   Ricciardi, Giuseppe K ^e   Beltramello, Alberto ^e   Johnson, Sterling C ^b,d   Frisoni, Giovanni B ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e MAGGIORE HOSPITAL   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Alzheimers disease (AD); Diffusion Tensor Imaging (DTI); Fractional Anisotropy (FA); Mean Diffusivity (MD); Microstructure

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MALE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; ULTRASTRUCTURE; VOXEL BASED MORPHOMETRY;

EID: 80055060529     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-0040     Document Type: Article

References (68)

1. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J (2003) White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 60, 393-398. (Pubitemid 36314365)
2. Bowen BC, Barker WW, Loewenstein DA, Sheldon J, Duara R (1990) MR signal abnormalities in memory disorder and dementia. AJNR Am J Neuroradiol 11, 283-290. (Pubitemid 20155062)
3. Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, KamphorstW(1995) Histopathologic correlates of white matter changes on MRI in Alzheimers disease and normal aging. Neurology 45, 883-888.
4. Vermersch P, Roche J, Hamon M, Daems-Monpeurt C, Pruvo JP, Dewailly P, Petit H (1996) White matter magnetic resonance imaging hyperintensity in Alzheimers disease: correlations with corpus callosum atrophy. J Neurol 243, 231-234. (Pubitemid 26071984)
5. Zhang Y, Schuff N, Du AT, Rosen HJ, Kramer JH, Gorno-Tempini ML, Miller BL, Weiner MW (2009) White matter damage in frontotemporal dementia and Alzheimers disease measured by diffusion MRI. Brain 132, 2579-2592.
6. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, OBrien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC (2001) Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 219, 101-107. (Pubitemid 32234060)
7. Rose SE, McMahon KL, Janke AL, ODowd B, de Zubicaray G, Strudwick MW, Chalk JB (2006) Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment. J Neurol Neurosurg Psychiatry 77, 1122-1128. (Pubitemid 44453245)
8. Beaulieu C (2002) The basis of anisotropic water diffusion in the nervous system -a technical review. NMR Biomed 15, 435-455. (Pubitemid 36054508)
9. Basser PJ, Pierpaoli C (1996) Microstructural and physiological features of tissues elucidated by quantitative-diffusiontensor MRI. J Magn Reson B 111, 209-219. (Pubitemid 126758682)
10. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di ChiroG(1996) Diffusion tensor MR imaging of the human brain. Radiology 201, 637-648.
11. Bronge L, Bogdanovic N, Wahlund LO (2002) Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement Geriatr Cogn Disord 13, 205-212. (Pubitemid 34507605)
12. Englund E (1998) Neuropathology of white matter changes in Alzheimers disease and vascular dementia. Dement Geriatr Cogn Disord 9(Suppl 1), 6-12. (Pubitemid 28325636)
13. Moseley M (2002) Diffusion tensor imaging and aging -a review. NMR Biomed 15, 553-560. (Pubitemid 36054515)
14. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, OBrien PC, Shiung MM, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr (2005) DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64, 902-904. (Pubitemid 40316336)
15. Allen G, Barnard H, McColl R, Hester AL, Fields JA,Weiner MF, Ringe WK, Lipton AM, Brooker M, McDonald E, Rubin CD, Cullum CM (2007) Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol 64, 1482-1487. (Pubitemid 47572671)
16. Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, Comi G, Filippi M (2002) White matter damage in Alzheimers disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 72, 742-746. (Pubitemid 34557017)
17. Choi SJ, Lim KO, Monteiro I, Reisberg B (2005) Diffusion tensor imaging of frontal white matter microstructure in early Alzheimers disease: a preliminary study. J Geriatr Psychiatry Neurol 18, 12-19. (Pubitemid 40313186)
18. Hanyu H, Sakurai H, Iwamoto T, Takasaki M, Shindo H, Abe K (1998) Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimers disease. J Neurol Sci 156, 195-200. (Pubitemid 28186474)
19. Naggara O, Oppenheim C, Rieu D, Raoux N, Rodrigo S, Dalla Barba G, Meder JF (2006) Diffusion tensor imaging in early Alzheimers disease. Psychiatry Res 146, 243-249. (Pubitemid 44218939)
20. Sandson TA, Felician O, Edelman RR, Warach S (1999) Diffusion-weighted magnetic resonance imaging in Alzheimers disease. Dement Geriatr Cogn Disord 10, 166-171. (Pubitemid 29099702)
21. Fellgiebel A, Wille P, Muller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P (2004) Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord 18, 101-108. (Pubitemid 38822746)
22. Medina D, DeToledo-Morrell L, Urresta F, Gabrieli JD, Moseley M, Fleischman D, Bennett DA, Leurgans S, Turner DA, Stebbins GT (2006) White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging 27, 663-672.
23. Rose SE, Janke AL, Chalk JB (2008) Gray and white matter changes in Alzheimers disease: a diffusion tensor imaging study. J Magn Reson Imaging 27, 20-26.
24. Xie S, Xiao JX, Gong GL, Zang YF,Wang YH,Wu HK, Jiang XX (2006) Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 66, 1845-1849. (Pubitemid 44049814)
25. Salat DH, Tuch DS, Hevelone ND, Fischl B, Corkin S, Rosas HD, DaleAM(2005) Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann N Y Acad Sci 1064, 37-49. (Pubitemid 43030947)
26. Abe O, Yamasue H, Aoki S, Suga M, Yamada H, Kasai K, Masutani Y, Kato N, Ohtomo K (2008) Aging in the CNS: comparison of gray/white matter volume and diffusion tensor data. Neurobiol Aging 29, 102-116. (Pubitemid 350102706)
27. Fjell AM,Westlye LT, Greve DN, Fischl B, Benner T, van der Kouwe AJ, Salat D, Bjornerud A, Due-Tonnessen P,Walhovd KB (2008) The relationship between diffusion tensor imaging and volumetry as measures of white matter properties. Neuroimage 42, 1654-1668.
28. Hayakawa N, Kato H, Araki T (2007) Age-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector. Mech Ageing Dev 128, 311-316. (Pubitemid 46590305)
29. Hugenschmidt CE, Peiffer AM, Kraft RA, Casanova R, Deibler AR, Burdette JH, Maldjian JA, Laurienti PJ (2008) Relating imaging indices of white matter integrity and volume in healthy older adults. Cereb Cortex 18, 433-442. (Pubitemid 351197803)
30. Casanova R, Srikanth R, Baer A, Laurienti PJ, Burdette JH, Hayasaka S, Flowers L, Wood F, Maldjian JA (2007) Biological parametric mapping: A statistical toolbox for multimodality brain image analysis. Neuroimage 34, 137-143. (Pubitemid 44765265)
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology 34, 939-944. (Pubitemid 14076461)
32. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412-2414. (Pubitemid 23346995)
33. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state"A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
34. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7, 486-488. (Pubitemid 10073130)
35. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26, 839-851. (Pubitemid 40825026)
36. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38, 95-113. (Pubitemid 47440133)
37. McLaren DG, Kosmatka KJ, Kastman EK, Bendlin BB, Johnson SC Rhesus macaque brain morphometry: a methodological comparison of voxel-wise approaches. Methods 50, 157-165.
38. Behrens TE, Woolrich MW, Jenkinson M, Johansen-Berg H, Nunes RG, Clare S, Matthews PM, Brady JM, Smith SM (2003) Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 50, 1077-1088. (Pubitemid 37356588)
39. Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5, 143-156. (Pubitemid 35282800)
40. Fellgiebel A, Muller MJ, Wille P, Dellani PR, Scheurich A, Schmidt LG, Stoeter P (2005) Color-coded diffusion-tensorimaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol Aging 26, 1193-1198. (Pubitemid 40726012)
41. Salat DH, Tuch DS, van der Kouwe AJ, Greve DN, Pappu V, Lee SY, Hevelone ND, Zaleta AK, Growdon JH, Corkin S, Fischl B, Rosas HD (2008) White matter pathology isolates the hippocampal formation in Alzheimers disease. Neurobiol Aging.
42. Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, Mueller S, Du AT, Kramer JH, Yaffe K, Chui H, Jagust WJ, Miller BL, Weiner MW (2007) Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 68, 13-19. (Pubitemid 46058544)
43. Camara E, Bodammer N, Rodriguez-Fornells A,Tempelmann C(2007) Age-relatedwater diffusion changes in human brain: a voxel-based approach. Neuroimage 34, 1588-1599. (Pubitemid 46187063)
44. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, DoddrellDM(2000) Loss of connectivity in Alzheimers disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 69, 528-530.
45. Teipel SJ, Stahl R, Dietrich O, Schoenberg SO, Perneczky R, Bokde AL, Reiser MF, Moller HJ, Hampel H (2007) Multivariate network analysis of fiber tract integrity in Alzheimers disease. Neuroimage 34, 985-995. (Pubitemid 46394457)
46. Honig LS, Mayeux R (2001) Natural history of Alzheimers disease. Aging (Milano) 13, 171-182.
47. Braak H, Braak E (1990) Alzheimers disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol 49, 215-224. (Pubitemid 20155922)
48. SuvaD, Favre I, Kraftsik R, Esteban M, Lobrinus A, Miklossy J (1999) Primary motor cortex involvement in Alzheimer disease. J Neuropathol Exp Neurol 58, 1125-1134. (Pubitemid 29519836)
49. Golaz J, Bouras C, Hof PR (1992) Motor cortex involvement in presenile dementia: report of a case. J Geriatr Psychiatry Neurol 5, 85-92.
50. Jagust WJ,Davies P, Tiller-Borcich JK, ReedBR(1990) Focal Alzheimers disease. Neurology 40, 14-19.
51. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5, 863-873. (Pubitemid 39482155)
52. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA (1995) Transferrin and iron in normal, Alzheimers disease, and Parkinsons disease brain regions. J Neurochem 65, 710-724.
53. Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR (1994) In vivo evaluation of brain iron in Alzheimers disease and normal subjects using MRI. Biol Psychiatry 35, 480-487. (Pubitemid 24122331)
54. Frisoni GB, Prestia A, Rasser PE, Bonetti M, Thompson PM (2009) In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimers disease. J Neurol 256, 916-924.
55. Busatto GF, Diniz BS, Zanetti MV (2008) Voxel-based morphometry in Alzheimers disease. Expert Rev Neurother 8, 1691-1702.
56. Chaim TM, Duran FL, Uchida RR, Perico CA, de Castro CC, Busatto GF (2007) Volumetric reduction of the corpus callosum in Alzheimers disease in vivo as assessed with voxel-based morphometry. Psychiatry Res 154, 59-68. (Pubitemid 46072704)
57. Stoub TR, deToledo-Morrell L, Stebbins GT, Leurgans S, Bennett DA, Shah RC (2006) Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimers disease. Proc Natl Acad Sci U S A 103, 10041-10045. (Pubitemid 43993619)
58. Villain N, Desgranges B,Viader F, de la SayetteV, Mezenge F, Landeau B, Baron JC, Eustache F, ChetelatG(2008) Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimers disease. J Neurosci 28, 6174-6181.
59. Peters A, Moss MB, Sethares C (2000) Effects of aging on myelinated nerve fibers in monkey primary visual cortex. J Comp Neurol 419, 364-376. (Pubitemid 30134146)
60. Peters A, Sethares C (2002) Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey. J Comp Neurol 442, 277-291. (Pubitemid 34024374)
61. Wozniak JR, Lim KO (2006) Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev 30, 762-774. (Pubitemid 44292285)
62. Brun A, Gustafson L, Englund E (1990) Subcortical pathology of Alzheimers disease. Adv Neurol 51, 73-77.
63. Iwamoto N, Nishiyama E, Ohwada J, Arai H (1997) Distribution of amyloid deposits in the cerebral white matter of the Alzheimers disease brain: relationship to blood vessels. Acta Neuropathol 93, 334-340. (Pubitemid 27153699)
64. Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, Hsu CY (2001) Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci 21, RC118.
65. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791-1800. (Pubitemid 34663580)
66. Higuchi M, Lee VM, Trojanowski JQ (2002) Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med 2, 131-150. (Pubitemid 37012501)
67. Lee VM, Daughenbaugh R, Trojanowski JQ (1994) Microtubule stabilizing drugs for the treatment of Alzheimers disease. Neurobiol Aging 15(Suppl 2), S87-S89.
68. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33, 403-408. (Pubitemid 23358066)